推荐产品
材料
PVDF
polypropylene
polypropylene support
silicone seal
品質等級
法律遵循
meets EU framework regulation [1935/2004/EC] (all component materials; regarding materials and articles intended to contact food)
meets FDA Indirect Food Additive requirements cited in 21 CFR 177-182 (all component materials)
無菌
non-sterile
滅菌相容性
autoclavable compatible
steam-in-place compatible
產品線
Durapore®
EMPROVE® Filter
特點
hydrophilic
製造商/商標名
Durapore®
參數
≤6.6 mL/min air diffusion at 2.75 bar (40 psig) and 23 °C (in water)
0.35 bar max. differential pressure (5 psid) at 135 °C (Forward)
0.35 bar max. inlet pressure (5 psi) at 135 °C (Forward)
1.7 bar max. differential pressure (25 psid) at 80 °C (Forward)
1.7 bar max. inlet pressure (25 psi) at 80 °C (Forward)
25 L/min flow rate at 1.4 bar (ΔP)
3.5 bar max. differential pressure (50 psid) at 25 °C (Reverse)
3.5 bar max. inlet pressure (50 psi) at 25 °C (Reverse)
5.5 bar max. differential pressure (80 psid) at 25 °C (Forward)
5.5 bar max. inlet pressure (80 psi) at 25 °C (Forward)
技術
sterile filtration: suitable
長度
5 in.
寬度
2.7 in.
柱標稱長度
5 in. (12.5 cm)
直徑
6.9 cm (2.7 in.)
過濾面積
0.35 m2
雜質
≤0.5 EU/mL bacterial endotoxins (LAL test, Aqueous extraction)
<0.5 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)
重量法萃取物
≤10 mg/cartridge
基質
Durapore®
孔徑
0.22 μm pore size
輸入
sample type liquid
起泡點
≥3450 mbar (50 psig), air with water at 23 °C
柱代碼
Code 7 (2-226; O-rings w/locking-tabs)
正在寻找类似产品? 访问 产品对比指南
一般說明
包裝
其他說明
- 生物截留:微生物
- 作用机制:过滤(体积排阻)
- 应用:生物处理
- 预期用途:减少或去除微生物/生物负荷
- 使用说明:请参阅《Durapore®薄膜用户指南》中的过滤器单元润湿说明
- 储存条件:干燥储存
- 处置声明:根据国家、省市和当地适用法规处置。
準備報告
30个SIP循环,30 min @ 135 °C; 30个高压灭菌循环,60 min @ 126 °C
分析報告
使用ASTM® F838方法,对样品进行最小保留的缺陷短波单孢菌挑战浓度为 1 × 10⁷ CFU/cm² 的定量保留。
法律資訊
未找到合适的产品?
试试我们的产品选型工具.
商品
Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).
Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).
Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).
Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门